NYSEMKT: OSTX
Os Therapies Inc Stock Ownership - Who owns Os Therapies?

Insider buying vs selling

Have Os Therapies Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when OSTX insiders and whales buy or sell their stock.

OSTX Shareholders

What type of owners hold Os Therapies Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Shalom Auerbach6.80%2,687,570$4.65MInsider
Paul A. Romness6.26%2,473,000$4.28MInsider
Vanguard Group Inc1.37%540,421$934.93kInstitution
Theodore F. Search1.15%455,835$788.59kInsider
John Ciccio1.15%455,835$788.59kInsider
CM Management LLC1.01%400,000$692.00kInstitution
Geode Capital Management LLC0.62%246,038$425.65kInstitution
Colin Goddard0.57%225,179$389.56kInsider
Robert Petit0.51%200,000$346.00kInsider
Marshall Wace LLP0.28%109,949$190.21kInstitution

1 of 3

OSTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
OSTX4.49%16.72%
IBO1.34%2.84%Net SellingNet Selling
ANVS14.95%18.28%Net BuyingNet Buying
IMA31.17%68.83%Net Buying
FLNA27.93%72.07%Net Buying

Os Therapies Stock Ownership FAQ

Who owns Os Therapies?

Os Therapies (NYSEMKT: OSTX) is owned by 4.49% institutional shareholders, 16.72% Os Therapies insiders, and 78.78% retail investors. Shalom Auerbach is the largest individual Os Therapies shareholder, owning 2.69M shares representing 6.80% of the company. Shalom Auerbach's Os Therapies shares are currently valued at $4.65M.

If you're new to stock investing, here's how to buy Os Therapies stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.